Literature DB >> 9374124

Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study.

M B Katan1, J P Deslypere, A P van Birgelen, M Penders, M Zegwaard.   

Abstract

Tissue levels of n-3 fatty acids reflect dietary intake, but quantitative data about rate of incorporation and levels as a function of intake are scarce. We fed 58 men 0, 3, 6, or 9 g/d of fish oil for 12 months and monitored fatty acids in serum cholesteryl esters, erythrocytes, and subcutaneous fat during and after supplementation. Eicosapentaenoic acid (EPA) in cholesteryl esters plateaued after 4-8 weeks; the incorporation half-life was 4.8 days. Steady-state levels increased by 3.9 +/- 0.3 mass % points (+/- SE) for each extra gram of EPA eaten per day. Incorporation of docosahexaenoic acid (DHA) was erratic; plateau values were 1.1 +/- 0.1 mass % higher for every g/d ingested. Incorporation of EPA into erythrocyte membranes showed a half-life of 28 days; a steady state was reached after 180 days. Each g/d increased levels by 2.1 +/- 0.1 mass %. C22:5n-3 levels increased markedly. Changes in DHA were erratic and smaller. EPA levels in adipose tissue rose also; the change after 6 months was 67% of that after 12 months in gluteal and 75% in abdominal fat. After 12 months each gram per day caused an 0.11 +/- 0.01 mass % rise in gluteal fat for EPA, 0.53 +/- 0.07 for C22:5n-3, and 0.14 +/- 0.03 for DHA. Thus, different (n-3) fatty acids were incorporated with different efficiencies, possibly because of interconversions or different affinities of the enzymatic pathways involved. EPA levels in cholesteryl esters reflect intake over the past week or two, erythrocytes over the past month or two, and adipose tissue over a period of years. These findings may help in assessing the intake of (n-3) fatty acids in epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374124

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  199 in total

Review 1.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

2.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Authors:  William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

3.  Cross-sectional study of conjugated linoleic acid in adipose tissue and risk of diabetes.

Authors:  Nelsy Castro-Webb; Edward A Ruiz-Narváez; Hannia Campos
Journal:  Am J Clin Nutr       Date:  2012-05-30       Impact factor: 7.045

4.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

5.  Red blood cell delta15N: a novel biomarker of dietary eicosapentaenoic acid and docosahexaenoic acid intake.

Authors:  Diane M O'Brien; Alan R Kristal; M Alyssa Jeannet; Michael J Wilkinson; Andrea Bersamin; Bret Luick
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

Review 6.  Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

7.  Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research.

Authors:  Beth A MacIntosh; Christopher E Ramsden; Keturah R Faurot; Daisy Zamora; Margaret Mangan; Joseph R Hibbeln; J Douglas Mann
Journal:  Br J Nutr       Date:  2013-01-18       Impact factor: 3.718

8.  A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.

Authors:  Yu-Han Chiu; Kimberly A Bertrand; Shumin Zhang; Francine Laden; Mara M Epstein; Bernard A Rosner; Stephanie Chiuve; Hannia Campos; Edward L Giovannucci; Jorge E Chavarro; Brenda M Birmann
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

9.  Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?

Authors:  N Coley; R Raman; M C Donohue; P S Aisen; B Vellas; S Andrieu
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

10.  Changes of molecular glycerophospholipid species in plasma and red blood cells during docosahexaenoic acid supplementation.

Authors:  Olaf Uhl; Hans Demmelmair; Mario Klingler; Berthold Koletzko
Journal:  Lipids       Date:  2013-09-17       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.